Summit Therapeutics Goodwill

The latest goodwill for SMMT is $2M as of June 2026. That compares with $2M in the prior-year period — down 3.5% year over year. Investors often review this figure alongside Summit Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, SMMT's goodwill moved from $2M to $2M — a 3.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Summit Therapeutics's operating scale or balance-sheet position.

A goodwill figure of $2M for SMMT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SMMT's goodwill ($2M), review year-over-year change from $2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.